KPTI vs AAPL: Which Stock is Better?
Side-by-side comparison of Karyopharm Therapeutics Inc and Apple Inc in 2026
KPTI
Karyopharm Therapeutics Inc
$8.28
AAPL
Apple Inc
$258.66
Key Metrics Comparison
| Metric | KPTI | AAPL | Winner |
|---|---|---|---|
| Market Cap | $186.66M | N/A | KPTI |
| P/E Ratio | N/A | 32.77 | AAPL |
| EPS (TTM) | $N/A | $7.91 | AAPL |
| Revenue Growth | 0.1% | 0.2% | AAPL |
| Gross Margin | 9.9% | 47.3% | AAPL |
Analyze KPTI
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KPTI or AAPL a better investment?
Comparing KPTI and AAPL: Karyopharm Therapeutics Inc has a market cap of $186.66M while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KPTI and AAPL?
KPTI (Karyopharm Therapeutics Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KPTI or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KPTI or AAPL?
AAPL has higher revenue growth at 0.2% vs 0.1% for KPTI.
Which company is more profitable: KPTI or AAPL?
Apple Inc (AAPL) has higher gross margins at 47.3% compared to 9.9% for KPTI.
Which is the larger company: KPTI or AAPL?
Karyopharm Therapeutics Inc (KPTI) is larger with a market cap of $186.66M compared to N/A for AAPL.
Should I buy KPTI or AAPL in 2026?
Both KPTI and AAPL have investment merit. KPTI trades at $8.28 while AAPL trades at $258.66. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KPTI and AAPL stock?
Key differences: Market Cap ($186.66M vs N/A), P/E Ratio (N/A vs 32.8x), Revenue Growth (0.1% vs 0.2%), Gross Margin (9.9% vs 47.3%).